{"id":"https://openalex.org/W2370524337","doi":null,"title":"Screening of agonist for glucagon-like peptide-1 receptor and its effect on PC12 cells","display_name":"Screening of agonist for glucagon-like peptide-1 receptor and its effect on PC12 cells","publication_year":2007,"publication_date":"2007-01-01","ids":{"openalex":"https://openalex.org/W2370524337","mag":"2370524337"},"language":"en","primary_location":{"id":"mag:2370524337","doi":null,"is_oa":false,"landing_page_url":"https://europepmc.org/article/CBA/633718","pdf_url":null,"source":{"id":"https://openalex.org/S2764966987","display_name":"Zh\u014dnghu\u00e1 y\u00e0oxu\u00e9 z\u00e1zh\u00ec","issn_l":"1016-1015","issn":["1016-1015"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4323237738","host_organization_name":"Pharmaceutical Society of the Republic of China","host_organization_lineage":["https://openalex.org/P4323237738"],"host_organization_lineage_names":["Pharmaceutical Society of the Republic of China"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zh\u014dnghu\u00e1 y\u00e0oxu\u00e9 z\u00e1zh\u00ec","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112315580","display_name":"Fei Yin","orcid":"https://orcid.org/0000-0002-1075-0951","observed_orcids":["https://orcid.org/0000-0002-1075-0951"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fei Yin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100950158","display_name":"Deng Xiao-hong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Deng Xiao-hong","raw_affiliation_strings":["~a,JING Jia-jia~"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"~a,JING Jia-jia~","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110831815","display_name":"Jiajia Jing","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jing Jiajia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027540779","display_name":"Zheng Xu-xu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zheng Xu-xu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100357342","display_name":"Jianhui Liu","orcid":"https://orcid.org/0000-0001-8921-7350","observed_orcids":["https://orcid.org/0000-0001-8921-7350","https://orcid.org/0009-0008-8306-6721"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jianhui Liu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8921-7350","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.29378615,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"24","last_page":"27"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13677","display_name":"Magnolia and Illicium research","score":0.13819999992847443,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13677","display_name":"Magnolia and Illicium research","score":0.13819999992847443,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.1031000018119812,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.09700000286102295,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor","display_name":"GLP-1 receptor","score":0.9739999771118164},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8830000162124634},{"id":"https://openalex.org/keywords/geniposide","display_name":"geniposide","score":0.9929999709129333},{"id":"https://openalex.org/keywords/pc12-cells","display_name":"PC12 cells","score":0.9760000109672546},{"id":"https://openalex.org/keywords/neuronal-differentiation","display_name":"neuronal differentiation","score":0.9940000176429749},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.9580000042915344},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.6959999799728394},{"id":"https://openalex.org/keywords/hydrogen-peroxide","display_name":"hydrogen peroxide","score":0.9649999737739563},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9879999756813049},{"id":"https://openalex.org/keywords/neurotrophic-effects","display_name":"neurotrophic effects","score":0.7929999828338623},{"id":"https://openalex.org/keywords/natural-product-screening","display_name":"natural product screening","score":0.800000011920929}],"concepts":[{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.8648291230201721},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6210730671882629},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.5861661434173584},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5661290884017944},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.544416069984436},{"id":"https://openalex.org/C92020748","wikidata":"https://www.wikidata.org/wiki/Q420457","display_name":"Neurotrophin","level":3,"score":0.5130075812339783},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.41868042945861816},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4119289219379425},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3482311964035034},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3215596675872803},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.30283427238464355},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25155991315841675},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2244035005569458}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2370524337","doi":null,"is_oa":false,"landing_page_url":"https://europepmc.org/article/CBA/633718","pdf_url":null,"source":{"id":"https://openalex.org/S2764966987","display_name":"Zh\u014dnghu\u00e1 y\u00e0oxu\u00e9 z\u00e1zh\u00ec","issn_l":"1016-1015","issn":["1016-1015"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4323237738","host_organization_name":"Pharmaceutical Society of the Republic of China","host_organization_lineage":["https://openalex.org/P4323237738"],"host_organization_lineage_names":["Pharmaceutical Society of the Republic of China"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zh\u014dnghu\u00e1 y\u00e0oxu\u00e9 z\u00e1zh\u00ec","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1971636741","https://openalex.org/W3141678312","https://openalex.org/W2107387649","https://openalex.org/W2051480891","https://openalex.org/W1014765493","https://openalex.org/W1992788138","https://openalex.org/W2011200899","https://openalex.org/W4248217399","https://openalex.org/W3149092726","https://openalex.org/W1535374793"],"abstract_inverted_index":{"OBJECTIVE":[0],"To":[1],"screen":[2,18],"the":[3,20,27,33,45,68,72],"agonist":[4,40,73],"for":[5,41,74],"glucagon-like":[6],"peptide-1":[7],"receptor,and":[8,26],"evaluate":[9],"its":[10],"neuronal":[11,46],"activity.METHODS":[12],"Natural":[13],"products":[14],"were":[15],"collected":[16],"to":[17],"in":[19,32],"stable":[21],"cell":[22],"line":[23],"of":[24,48],"GLP-1":[25,42,75],"active":[28],"component":[29],"was":[30,37],"identified":[31],"PC12":[34,49,57],"cells.RESULTS":[35],"Geniposide":[36,66],"a":[38],"novel":[39],"receptor,which":[43],"induced":[44,62],"differentiation":[47],"cells":[50,58],"via":[51],"mitogen-activated":[52],"protein":[53],"kinase":[54],"pathway,and":[55],"prevented":[56],"from":[59],"oxidative":[60],"damage":[61],"by":[63],"hydrogen":[64],"peroxide.CONCLUSION":[65],"has":[67],"similar":[69],"function":[70],"as":[71],"receptor,including":[76],"neurotrophic":[77],"and":[78],"neuroprotective":[79],"effects.":[80]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}